192 related articles for article (PubMed ID: 34419073)
1. NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway.
Wu Y; Lin Y; Pan J; Tu X; Xu Y; Li H; Chen Y
Cancer Cell Int; 2021 Aug; 21(1):443. PubMed ID: 34419073
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma.
Wang X; Tian X; Sui X; Li X; Zhao X; Han K; Sun L; Dong Y
Bioengineered; 2022 Mar; 13(3):6113-6125. PubMed ID: 35254214
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
[TBL] [Abstract][Full Text] [Related]
4. AC099850.3/NCAPG Axis Predicts Poor Prognosis and is Associated with Resistance to EGFR Tyrosine-Kinase Inhibitors in Lung Adenocarcinoma.
Bao J; Wu Y; Zhang K; Qi H
Int J Gen Med; 2022; 15():6917-6930. PubMed ID: 36061963
[TBL] [Abstract][Full Text] [Related]
5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
6. NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition by activating the Wnt/β-catenin signaling pathway.
Shi Y; Ge C; Fang D; Wei W; Li L; Wei Q; Yu H
Cancer Cell Int; 2022 Mar; 22(1):119. PubMed ID: 35292013
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of NCAPG mediated by E2F1 facilitates the progression of osteosarcoma through the Wnt/β-catenin signaling pathway.
Luo G; Cheng H; Fan J; Sun T
Transl Cancer Res; 2024 May; 13(5):2437-2450. PubMed ID: 38881929
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
9. Low expression of CHRDL1 and SPARCL1 predicts poor prognosis of lung adenocarcinoma based on comprehensive analysis and immunohistochemical validation.
Deng H; Hang Q; Shen D; Zhang Y; Chen M
Cancer Cell Int; 2021 May; 21(1):259. PubMed ID: 33980221
[TBL] [Abstract][Full Text] [Related]
10. NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis.
Zhang Z; Qi D; Liu X; Kang P
Clin Respir J; 2023 Sep; 17(9):884-892. PubMed ID: 37553792
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
12. Fucosyltransferase 2 induced epithelial-mesenchymal transition via TGF-β/Smad signaling pathway in lung adenocarcinaoma.
Deng G; Chen L; Zhang Y; Fan S; Li W; Lu J; Chen X
Exp Cell Res; 2018 Sep; 370(2):613-622. PubMed ID: 30031128
[TBL] [Abstract][Full Text] [Related]
13. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
14. GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway.
Wang J; Xu M; Li DD; Abudukelimu W; Zhou XH
Open Med (Wars); 2021; 16(1):24-32. PubMed ID: 33364431
[TBL] [Abstract][Full Text] [Related]
15. Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer.
Xu T; Dong M; Wang Z; Li H; Li X
Cancer Manag Res; 2020; 12():5773-5786. PubMed ID: 32765080
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential oncogenes in triple-negative breast cancer based on bioinformatics analyses.
Xiao X; Zhang Z; Luo R; Peng R; Sun Y; Wang J; Chen X
Oncol Lett; 2021 May; 21(5):363. PubMed ID: 33747220
[TBL] [Abstract][Full Text] [Related]
17. Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway.
Zhang T; Xia W; Song X; Mao Q; Huang X; Chen B; Liang Y; Wang H; Chen Y; Yu X; Zhang Z; Yang W; Xu L; Dong G; Jiang F
J Hematol Oncol; 2022 Aug; 15(1):114. PubMed ID: 35982471
[TBL] [Abstract][Full Text] [Related]
18. DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma.
Fan W; Xing Y; Yan S; Liu W; Ning J; Tian F; Wang X; Zhan Y; Luo L; Cao M; Huang J; Cai L
Cancer Cell Int; 2024 Jun; 24(1):208. PubMed ID: 38872157
[TBL] [Abstract][Full Text] [Related]
19. Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis.
Chen Y; Jin L; Jiang Z; Liu S; Feng W
Front Oncol; 2021; 11():644426. PubMed ID: 33937050
[TBL] [Abstract][Full Text] [Related]
20.
Yang H; Pu L; Li R; Zhu R
J Gastrointest Oncol; 2023 Apr; 14(2):900-912. PubMed ID: 37201048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
